Health Catalyst (HCAT) Tops Q4 EPS by 2c

Health Catalyst (NASDAQ: HCAT) reported Q4 EPS of ($0.19), $0.02 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $64.71 million versus the consensus estimate of $63.14 million.

GUIDANCE:

Health Catalyst sees FY2022 revenue of $287.8-292.8 million, versus the consensus of $291.5 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Paramount Global (PARA) Tops Q2 EPS by 175c
• Femasys Inc. (FEMY) Misses Q2 EPS by 20c